The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes.

W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology.

The Mid-South Clinical Data Research Network, led by Vanderbilt University’s Russell Rothman, M.D., M.P.P., has been approved for a three-year, $8.5 million funding award from the independent Patient-Centered Outcomes Research Institute (PCORI) to expand its efforts to improve healthcare throughout the Southeast.

A team of Vanderbilt and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research.

Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known.

Russell Rothman, M.D., MPP, professor of Medicine, Pediatrics and Health Policy, chief of the Section of Internal Medicine and Pediatrics and director of the Vanderbilt Center for Health Services Research, has been named assistant vice chancellor for Population Health Research.

The gut has its own built-in pacemakers, populations of specialized cells that control smooth muscle contraction in the stomach, small intestine and colon.